Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL389205 | 0.98 | GPR119 (0.66) | GPR119CYP2C9 | |
| SCHEMBL390447 | 0.97 | GPR119 (0.68) | GPR119CYP2C9 | |
| SCHEMBL4454353 | 0.91 | GPR119 (0.57) | GPR119CYP2C9 | |
| SCHEMBL386100 | 0.90 | GPR119 (0.64) | GPR119CYP2C9 | |
| SCHEMBL1889155 | 0.89 | GPR119 (0.64) | GPR119CYP2C9 | |
| SCHEMBL389473 | 0.89 | GPR119 (0.70) | GPR119CYP2C9 | |
| SCHEMBL390879 | 0.88 | GPR119 (0.74) | GPR119CYP2C9 | |
| SCHEMBL388981 | 0.88 | GPR119 (0.66) | GPR119CYP2C9 | |
| SCHEMBL390782 | 0.88 | GPR119 (0.65) | GPR119CYP2C9 | |
| SCHEMBL390765 | 0.88 | GPR119 (0.67) | GPR119CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2116235-A1 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | Arena Pharmaceuticals, Inc. (US) | 2009-11-11 | — | — | EP | disclosed |